Correlation Between Salesforce and Bellerophon Therapeutics
Can any of the company-specific risk be diversified away by investing in both Salesforce and Bellerophon Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Bellerophon Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Bellerophon Therapeutics, you can compare the effects of market volatilities on Salesforce and Bellerophon Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Bellerophon Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Bellerophon Therapeutics.
Diversification Opportunities for Salesforce and Bellerophon Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Salesforce and Bellerophon is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Bellerophon Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bellerophon Therapeutics and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Bellerophon Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bellerophon Therapeutics has no effect on the direction of Salesforce i.e., Salesforce and Bellerophon Therapeutics go up and down completely randomly.
Pair Corralation between Salesforce and Bellerophon Therapeutics
If you would invest 18,626 in Salesforce on December 5, 2024 and sell it today you would earn a total of 10,108 from holding Salesforce or generate 54.27% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Salesforce vs. Bellerophon Therapeutics
Performance |
| Timeline |
| Salesforce |
| Bellerophon Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Salesforce and Bellerophon Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Salesforce and Bellerophon Therapeutics
The main advantage of trading using opposite Salesforce and Bellerophon Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Bellerophon Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bellerophon Therapeutics will offset losses from the drop in Bellerophon Therapeutics' long position.| Salesforce vs. Zoom Video Communications | ||
| Salesforce vs. C3 Ai Inc | ||
| Salesforce vs. Shopify | ||
| Salesforce vs. Workday |
| Bellerophon Therapeutics vs. Bio Path Holdings | ||
| Bellerophon Therapeutics vs. Capricor Therapeutics | ||
| Bellerophon Therapeutics vs. NextCure | ||
| Bellerophon Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |